175 results
Responsible body
CHMP Remove CHMP filter
-
List item
Press release: European Medicines Agency recommends approval of Mekinist for the treatment of melanoma
CHMP, Last updated: 25/04/2014metastatic melanoma with a BRAF V600 mutation. Mekinist is the … year, doctors diagnose almost 60,000 new cases and approximately … genetic mutation at position 600. Mutations of the BRAF protein … -
List item
Press release: European Medicines Agency recommends approval of Tafinlar for the treatment of metastatic melanoma
CHMP, Last updated: 28/06/2013melanoma expressing a BRAF V600 gene mutation. Melanoma is … year, doctors diagnose almost 60,000 new cases and approximately … approximately 8,300 men and 7,600 women die from this cancer … -
List item
Press release: European Medicines Agency recommends approval of first-in-class treatment for metastatic or unresectable melanoma
CHMP, Last updated: 16/12/2011melanoma patients with BRAF V600 mutations … melanoma patients with BRAF V600 mutations The European … unresectable melanoma with BRAF V600 mutations. Melanoma is … -
List item
Press release: CHMP recommends authorisation of new treatment for phenylketonuria, a rare inherited metabolic disease
CHMP, Last updated: 01/03/2019phenylalanine levels greater than 600 micromol/l) despite prior management … phenylalanine levels ≤ 600 micromol/l after 18 months … -
List item
Press release: European Medicines Agency recommends approval of new medicine for Cushing's disease
CHMP, Last updated: 20/01/2012of patients treated with a 600μg dose. In terms of safety … of patients treated with a 600μg dose. In terms of safety … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020
CHMP, Last updated: 24/07/2020Mycobacterium avium … -
List item
News: Public statement: Risk of peripheral neuropathy with Sebivo (telbivudine)
CHMP, Last updated: 14/02/2008combination therapy of telbivudine 600 mg daily with pegylated interferon … -
List item
Press release: European Medicines Agency recommends first-in-class medicine for treatment of cystic fibrosis
CHMP, Last updated: 25/05/2012disorder affecting around 60,000 people in the European Union … disorder affecting around 60,000 people in the European Union … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2014
CHMP, Last updated: 25/04/2014metastatic melanoma with a BRAF V600 mutation. Mekinist is the … -
List item
Press release: New treatment option recommended for patients with advanced melanoma
CHMP, Last updated: 22/05/2015monoclonal antibodies, BRAF V600 inhibitors and MEK inhibitors … monoclonal antibodies, BRAF V600 inhibitors and MEK inhibitors … -
List item
Press release: New treatment for advanced melanoma
CHMP, Last updated: 24/04/2015monoclonal antibodies, BRAF V600 and MEK inhibitors, have … monoclonal antibodies, BRAF V600 and MEK inhibitors, have … -
List item
Press release: European Medicines Agency recommends first-in-class medicine for treatment of Duchenne muscular dystrophy
CHMP, Last updated: 23/05/2014Union (EU), approximately 18,600 people have Duchenne muscular … Union (EU), approximately 18,600 people have Duchenne muscular … -
List item
Press release: European Medicines Agency recommends extending use of Nexavar to include treatment of differentiated thyroid cancer
CHMP, Last updated: 25/04/2014reported in 2012 and over 3,600 deaths. Differentiated thyroid … reported in 2012 and over 3,600 deaths. Differentiated thyroid … -
List item
Press release: European Medicines Agency agrees to precautionary recall of Advagraf 0.5 mg capsule batches
CHMP, Last updated: 20/10/20110M4006N, 0M4006E, 0M4006C, 0M6006T, 0M4006L, 0M4006B, 0M4006R … 0M4006K, 0M300 0M4006C, 0M6006T, 0M4006L, 0M4006B, 0M4006R … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018
CHMP, Last updated: 27/07/2018metastatic melanoma with a BRAF V600 mutation … -
List item
Press release: European Medicines Agency updates treatment recommendations because of continued Fabrazyme shortage
CHMP, Last updated: 06/07/2010medical needs of the nearly 600 patients receiving Fabrazyme … medical needs of the nearly 600 patients receiving Fabrazyme … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2020
CHMP, Last updated: 13/11/202013/11/2020 EMA/CHMP/SAWP/600410/2020 … -
List item
Press release: First oncolytic immunotherapy medicine recommended for approval
CHMP, Last updated: 23/10/2015including immunotherapies, BRAF V600 inhibitors and MEK inhibitors … including immunotherapies, BRAF V600 inhibitors and MEK inhibitors … -
List item
Press release: First-in-class treatment to lower cholesterol
CHMP, Last updated: 22/05/2015mixed dyslipidaemia (over 6,000 patients followed for at … mixed dyslipidaemia (over 6,000 patients followed for at … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 January 2008
CHMP, Last updated: 24/01/2008capsules, 200 mg, 400 mg, 600 mg film-coated tablets, (ribavirin … capsules, 200 mg, 400 mg, 600 mg film-coated tablets, (ribavirin … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,23-26 June 2008
CHMP, Last updated: 26/06/2008Rapinyl 50, 100, 200, 300, 400, 600 and 800 microgram (fentanyl … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2013
CHMP, Last updated: 28/06/2013metastatic melanoma with a BRAF V600 mutation; and … -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 May 2016
European Medicines Agency, London, UK, from 23/05/2016 to 26/05/2016, Last updated: 06/01/2014Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 … -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2016
European Medicines Agency, London, UK, from 20/06/2016 to 23/06/2016, Last updated: 06/01/2014Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 … -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 February 2016
European Medicines Agency, London, UK, from 22/02/2016 to 25/02/2016, Last updated: 06/01/2014Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 …